Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Cumberland Pharmaceuticals Inc.
  6. News
  7. Summary
    CPIX   US2307701092

CUMBERLAND PHARMACEUTICALS INC.

(CPIX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cumberland Pharmaceuticals Acquires US Rights to Sancuso Granisetron Patch From Kyowa Kirin

01/04/2022 | 01:09pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CUMBERLAND PHARMACEUTICALS INC. -0.93% 2.14 Delayed Quote.-53.75%
KIRIN HOLDINGS COMPANY, LIMITED -0.16% 1926.5 Delayed Quote.4.47%
KYOWA KIRIN CO. LTD. -1.37% 2734 Delayed Quote.-11.58%
All news about CUMBERLAND PHARMACEUTICALS INC.
05/13CUMBERLAND PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condi..
AQ
05/10CUMBERLAND : Q1 Earnings Snapshot
AQ
05/10Cumberland Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended Ma..
CI
05/10TRANSCRIPT : Cumberland Pharmaceuticals Inc., Q1 2022 Earnings Call, May 10, 2022
CI
05/10Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Posts Q1 Revenue $11.2M
MT
05/10Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q1 EPS $0.03
MT
05/10Cumberland Pharmaceuticals Reports 6% Revenue Growth
PR
05/09Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuti..
PR
05/09Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuti..
CI
05/03CUMBERLAND PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form..
AQ
More news
Financials (USD)
Sales 2021 36,0 M - -
Net income 2021 -3,51 M - -
Net cash 2021 11,0 M - -
P/E ratio 2021 -19,8x
Yield 2021 -
Capitalization 31,9 M 31,9 M -
EV / Sales 2020 0,98x
EV / Sales 2021 1,61x
Nbr of Employees 83
Free-Float 56,1%
Chart CUMBERLAND PHARMACEUTICALS INC.
Duration : Period :
Cumberland Pharmaceuticals Inc. Technical Analysis Chart | CPIX | US2307701092 | MarketScreener
Technical analysis trends CUMBERLAND PHARMACEUTICALS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
A. J. Kazimi Chairman & Chief Executive Officer
John M. Hamm Chief Financial & Accounting Officer
Leo B. Pavliv Chief Development Officer & EVP-Operations
James L. Herman Chief Compliance Officer & Senior Vice President
Gordon R. Bernard Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CUMBERLAND PHARMACEUTICALS INC.-53.75%32
SUN PHARMACEUTICAL INDUSTRIES LTD.9.03%28 546
OTSUKA HOLDINGS CO., LTD.8.01%19 119
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.-8.01%16 012
ONO PHARMACEUTICAL CO., LTD.24.90%13 633
CIPLA LIMITED2.75%10 099